(Q43812686)

English

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

scientific article published in December 2001

Statements

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia (English)
1 December 2001
2071-2074

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit